EFAVIRENZ
Generic: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Teva Pharmaceuticals USAManufacturer
ORALRoute
EFAVIRENZActive Substance
2018-11-09Original Approval
EFAVIRENZ is FDA application ANDA091215, sponsored by TEVA PHARMS USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
VIROLOGIC FAILURE
960 reports
2
DRUG INTERACTION
759 reports
3
DRUG RESISTANCE
742 reports
4
VIRAL MUTATION IDENTIFIED
676 reports
5
PATHOGEN RESISTANCE
641 reports
6
FOETAL EXPOSURE DURING PREGNANCY
620 reports
7
DEPRESSION
461 reports
8
MATERNAL EXPOSURE DURING PREGNANCY
432 reports
9
TREATMENT FAILURE
423 reports
10
ANAEMIA
417 reports